HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mee-Young Ahn Selected Research

apicidin

11/2018HDAC inhibitor apicidin suppresses murine oral squamous cell carcinoma cell growth in vitro and in vivo via inhibiting HDAC8 expression.
4/2017Histone deacetylase 7 silencing induces apoptosis and autophagy in salivary mucoepidermoid carcinoma cells.
4/2015Apicidin inhibits cell growth by downregulating IGF-1R in salivary mucoepidermoid carcinoma cells.
11/2011Apicidin, a histone deaceylase inhibitor, induces both apoptosis and autophagy in human oral squamous carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mee-Young Ahn Research Topics

Disease

11Neoplasms (Cancer)
03/2020 - 11/2011
7Squamous Cell Carcinoma of Head and Neck
11/2018 - 11/2011
3Necrosis
01/2018 - 08/2012
3Mouth Neoplasms (Oral Cancer)
01/2017 - 02/2012
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2012 - 11/2011
2Acute Kidney Injury (Acute Renal Failure)
01/2018 - 01/2017
2Mucoepidermoid Carcinoma
04/2017 - 04/2015
2Carcinogenesis
07/2012 - 02/2012
2Hypoxia (Hypoxemia)
07/2005 - 01/2002
1Oral Lichen Planus
03/2020
1Prostatic Neoplasms (Prostate Cancer)
03/2020
1Ischemia
01/2017
1Porcine Reproductive and Respiratory Syndrome (PRRS)
04/2016
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2015
1Hyperplasia
07/2012
1Lung Neoplasms (Lung Cancer)
03/2012
1Communicable Diseases (Infectious Diseases)
01/2012
1Infections
01/2012

Drug/Important Bio-Agent (IBA)

6Histone Deacetylase InhibitorsIBA
03/2020 - 11/2011
6Histone Deacetylases (Histone Deacetylase)IBA
03/2020 - 11/2011
4apicidinIBA
11/2018 - 11/2011
4Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2017 - 06/2012
3Histones (Histone)IBA
03/2020 - 11/2011
3Proteins (Proteins, Gene)FDA Link
01/2018 - 03/2012
31-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2017 - 01/2012
3Nuclear Antigens (Extractable Nuclear Antigens)IBA
11/2015 - 06/2012
2NucleotidesIBA
03/2020 - 04/2016
2Biological ProductsIBA
03/2020 - 07/2005
2Cisplatin (Platino)FDA LinkGeneric
01/2018 - 01/2017
2Therapeutic UsesIBA
01/2017 - 06/2012
2Photosensitizing Agents (Photosensitizers)IBA
01/2017 - 06/2012
2pheophorbide aIBA
01/2017 - 06/2012
2Biomarkers (Surrogate Marker)IBA
01/2017 - 07/2012
1Antineoplastic Agents (Antineoplastics)IBA
03/2020
1VorinostatFDA Link
03/2020
1Reactive Oxygen Species (Oxygen Radicals)IBA
03/2020
1Cyclic PeptidesIBA
11/2018
1Selenium-Binding ProteinsIBA
01/2017
1Pattern Recognition ReceptorsIBA
04/2016
15-nitro-5'-hydroxyindirubin-3'-oximeIBA
11/2015
1Chloroquine (Aralen)FDA LinkGeneric
11/2015
1Pharmaceutical PreparationsIBA
11/2015
1MucinsIBA
11/2015
1HMGB1 Protein (HMG1)IBA
08/2012
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
08/2012
1Imiquimod (Aldara)FDA LinkGeneric
08/2012
1Toll-Like Receptor 7IBA
08/2012
1Messenger RNA (mRNA)IBA
07/2012
1TransferasesIBA
07/2012
1Polo-Like Kinase 1IBA
03/2012
1NIMA-Interacting Peptidylprolyl IsomeraseIBA
03/2012
1indirubinIBA
03/2012
1trichostatin A (A 300)IBA
02/2012
1ChromatinIBA
02/2012
1theasinensin AIBA
02/2012
1necdinIBA
07/2005
1ErythropoietinFDA Link
01/2002
1Oxygen (Dioxygen)IBA
01/2002
1EnzymesIBA
01/2002
1Transcription Factors (Transcription Factor)IBA
01/2002
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2002

Therapy/Procedure

5Therapeutics
04/2017 - 01/2012
3Photochemotherapy (Photodynamic Therapy)
01/2017 - 01/2012
1Subcutaneous Injections
11/2018
1Intravenous Administration
06/2012